המוקטין SDH 1000 יחבל

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

HUMAN PLASMA COAGULATION FACTOR VIII

Disponible depuis:

KAMADA LTD, ISRAEL

Code ATC:

B02BD02

forme pharmaceutique:

אבקה וממס להכנת תמיסה להזרקה

Composition:

HUMAN PLASMA COAGULATION FACTOR VIII 100 IU/ML

Mode d'administration:

תוך-ורידי

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

BIOTEST PHARMA GMBH, GERMANY

Groupe thérapeutique:

COAGULATION FACTOR VIII

Domaine thérapeutique:

COAGULATION FACTOR VIII

indications thérapeutiques:

Treatment and prophylaxis of bleeding: in patients with haemophilia A (congenital factor VIII deficiency) in patient with acquired factor VIII deficiency.Haemoctin is not effective in controlling the bleeding of patients with Von Willebrond`s disease.

Date de l'autorisation:

2021-09-30